Cancer Center Amsterdam
-
Preclinical rationale for targeting the PD‐1/PD‐L1 axis in combination with a CD38 antibody in multiple myeloma and other CD38‐ positive malignancies
Verkleij, C. P. M., Jhatakia, A., Broekmans, M. E. C., Frerichs, K. A., Zweegman, S., Mutis, T., Bezman, N. A. & van de Donk, N. W. C. J., 1 Dec 2020, In: Cancers. 12, 12, p. 1-20 20 p., 3713.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications